Recent Finacing
Recent Raise
Regemat 3D develops configurable, modular 3D bioprinting platforms (FFF, IPF, IVF-compatible) plus software, bioreactors, materials and BIO V1/REG4LIFE printers for disease modeling, drug testing and organ-on-chip research.
